People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| International Stem Cell CORP | — | Biotechnology | Series A | $7.5M | $90.4M | 2012 |
Kurt May at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kurt May on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Donald Wright | 1 | 8 |
| Charles Casamento | 1 | 5 |
| Charles J Casamento | 1 | 5 |
| Paul Maier | 1 | 4 |
| Don Wright | 1 | 3 |
| Ruslan Semechkin | 1 | 1 |
| Sofya J. Bakalova | 1 | 1 |
| Simon Craw | 1 | 1 |
| Jay Novak | 1 | 1 |
| Linh Nguyen | 1 | 1 |
| James Berglund | 1 | 1 |
| Andrey Semechkin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.